The company’s physician business, Physician Sales & Service (PSS), expects to market and sell a minimum of two million doses of Fluvirin on behalf of Novartis Vaccines to office-based physicians in the upcoming 200-2009 influenza season. The company also said that, orders may be placed for Fluvirin influenza virus vaccine for the 2008-2009 influenza season through Physician Sales & Service offices located nationwide.